<DOC>
	<DOCNO>NCT02910804</DOCNO>
	<brief_summary>This open-label positron emission tomography/near infrared ( PET/NIRF ) study investigate imaging navigation performance evaluation efficacy dual modality image probe 68Ga-BBN-IRDye800CW glioblastoma ( GBM ) patient . A single dose 40μg/111-148 Mega-Becquerel ( MBq ) 1.0 mg/ml 68Ga-BBN-IRDye800CW inject intravenously operation intraoperative respectively . Visual semiquantitative method use assess PET image real-time margin localization surgical navigation .</brief_summary>
	<brief_title>IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery Patients With Glioblastoma</brief_title>
	<detailed_description>Non-invasive preoperative PET image evaluation real-time fluorescence-guided surgery would great help GBM patient . BBN , amino acid sequence Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 , extensively use development molecular probe image gastrin-releasing peptide receptor ( GRPR ) , member G protein-coupled receptor family bombesin receptor over-expressed various type cancer cell include glioblastoma multiforme . For interest clinical translation GRPR target dual modality probe , open label dual modality image PET/ NIFR study design investigate safety image guide performance 68Ga-BBN-IRDye800CW patient GBM .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>Must able provide write informed consent MRI image and/or pathological evidence Newly Diagnosed recurrence GBM Consisted condition mental illness Severe liver kidney disease serum creatinine &gt; 3.0 mg/dl ( 270 μΜ ) Any hepatic enzyme level 5 time normal upper limit Severe allergy hypersensitivity IV radiographic contrast Claustrophobia accept PET/CT scan Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>GBM</keyword>
	<keyword>GRPR</keyword>
	<keyword>IRDye800</keyword>
	<keyword>NIRF</keyword>
	<keyword>surgery</keyword>
</DOC>